cirsimaritin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
AbuDalo, R; Al-Hashimi, N; Alqudah, A; Alqudah, M; Alshaikh, HA; Athamneh, RY; Gammoh, O; Oqal, M; Qnais, E | 1 |
1 review(s) available for cirsimaritin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
1 other study(ies) available for cirsimaritin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Metformin; Rats; Streptozocin | 2023 |